Immunological Basis for Rapid Progression of Diabetes in Older NOD Mouse Recipients Post BM-HSC Transplantation.
Type I diabetes (T1D), mediated by autoreactive T cell destruction of insulin-producing islet beta cells, has been treated with bone marrow-derived hematopoietic stem cell (BM-HSC) transplantation. Older non-obese diabetic (NOD) mice recipients (3m, at disease-onset stage) receiving syngeneic BM-HSC...
Main Authors: | Nan Wang, Narendiran Rajasekaran, Tieying Hou, Claudia Macaubas, Elizabeth D Mellins |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4447290?pdf=render |
Similar Items
-
Transgene expression in various organs post BM-HSC transplantation
by: Nan Wang, et al.
Published: (2014-01-01) -
HSC70 is a novel binding partner involved in the capture of immunoglobulins on B cells in the NOD mouse
by: Emma Renman, et al.
Published: (2022-11-01) -
Immunologic Complications and Graft Survival in Crohn’s Disease and NOD2 Mutant Non-Crohn’s Disease Adult Recipients Following Intestine Transplantation
by: Leonid Belyayev, MD, et al.
Published: (2020-06-01) -
Immunological outcome in haploidentical HSC transplanted patients treated with IL-10-anergized donor T Cells
by: Rosa eBacchetta, et al.
Published: (2014-01-01) -
Immunologic monitoring in kidney transplant recipients
by: Natavudh Townamchai, et al.
Published: (2013-06-01)